维普中文期刊产品整合服务
61篇 您的检索式:作者名="Lui GY"
    题名 作者 年代 出处 被引量
1Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10cm in diameter显示文摘Lee NH Chau GY Lui WY 0,,:2
2Perioperative safety and prognosis in hepatoeellular carcinoma patients with impaired liver function显示文摘Hsia CY Lui WY Chau GY 2000J Am Coll Surg2000,190,:1
3Evaluation of effect of hemihepatic vascular occlusion and the Pringle maneuver during hepatic resection for patients with hepatocellular carcinoma and impaired liver function 显示文摘Chau GY Lui WY King KL 2005World J Surg2005,29,11:1
4Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma显示文摘Tsai TJ Chau GY Lui WY 2000Surgery2000,127,6:1
5Dp44mT targets theAKT, TGF-beta and ERK pathways via the metastasis suppressorNDRG1 in normal prostate epithelial cells and prostate cancercells显示文摘Dixon KM Lui GY Kovacevic Z 2013Br J Cancer2013,108,2:1
6Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection 显示文摘Chau GY Lui WY Chi CW 2007Eur J Surg Oncol2007,,:1
7Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patient with resectable hepatocellular carcinoma显示文摘Lei HJ Chau GY Lui WY 2006J Am Coll Surg2006,203,4:1
8Significance of serum hcpato- cyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection显示文摘Chau GY Lui WY Chi CW 2008Eur J Surg Oncol2008,34,3:1
9Perioperative safety and prognosis in hepatocellular carcinoma patients with impaired liver function 显示文摘Hsia CY Lui WY Chau GY 2000J Am Coil Surg2000,190,5:1
10Long-term results of hepatic resection for hepatoeellular carcinoma originating from the noncirrhotic liver显示文摘Chang CH Chau GY Lui WY 2004Arch Surg2004,139,3:1
11Perioperative safety and prognosis in hepatocellular carcinoma patients with impaired liver function显示文摘HSIA CY LUI WY CHAU GY 2000J Am Coil Surg2000,190,5:1
12The iron chelator, deferasirox, as a novel strategy for cancer Treatment : oral activity against human lung tumor xenografts and molecular mechanism of action 显示文摘Lui GY Obeidy P Ford SJ 2013Mol Pharmacol2013,83,1:1
13Risk factors associated with intraoperative major blood loss in patients with hepatocellu- lar carcinoma who underwent hepatic resection 显示文摘Li CH Chau GY Lui WY 2003J Chin Med Assoc2003,66,11:1
14Clinicopathologic features and factors related to survival of patients with small hepatocellular carcinoma after hepatic resection显示文摘Chen JY Chau GY Lui WY 2006Worid J Surg2006,27,3:1
15Evaluation of effect of hemihepatic vascular occlusion and the Pringle maneuver during hepatic resection for patients with hepatocellular carcinoma and impaired liver function 显示文摘Chau GY Lui WY King KL 2005World J Surg2005,29,11:1
16Cinicopathologic features and factors related to survival of patients with small hepatocellulor carcinoma afthe hepatic resection显示文摘Chen J Y Chau GY Lui W Y 2003World J Surg2003,27,3:1
17Cinicopathologic features and factors related to survival of patients with small hepatocellular carcinoma after hepatic resection显示文摘Chen J Y Chau GY Lui WY 2003World J Surg2003,27,3:1
18Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter 显示文摘Lee NH Chau GY Lui WY 1998B J Surg1998,85,:1
19Prognostic significance of surgical margin in hepatocellular carcinoma resection:an analysis of 165 Childs′ A patients显示文摘Chau GY Lui WY Tsay SH 1997J Surg Oncol1997,66,2:1
20Hepatic segmentectomy for curative resection of primary hepatocellular carcinoma显示文摘Lui WY Chau GY Loong CC 1995Arch Surg1995,130,:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费